Partner Content Partner Content SMi’s Ophthalmic Drugs Conference is only 4 weeks away! Only 4 Weeks Remain for Ophthalmic Drugs
Partner Content Partner Content Spotlight on Key Sessions at Ophthalmic Drugs this November Sessions at Ophthalmic Drugs
News Judge throws out Allergan patents, criticises Native America... Federal court throws out patents on Restasis
Partner Content Partner Content Exceptional speaker line-up for Ophthalmic Drugs Hear from Santen, Novaliq GmBh, Aptar Pharma and more
News FDA experts to vote on Spark's groundbreaking gene therapy Luxturna could be single life-changing injection
Partner Content Partner Content Emerging & New Technologies in Drug Development Emerging & New Technologies in Drug Development
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
